This announcement is a separate document:
亚太药业：北京国枫律师事务所关于浙江亚太药业股份有限公司亚药转债2024年第一次债券持有人会议的法律意见书
Asia Pacific Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on Zhejiang Asia Pacific Pharmaceutical Co., Ltd.\'s first bondholders\' meeting in 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated